Aptar Group business segment dedicated to the evolving needs of biotechnology, healthcare and pharmaceutical companies with innovative drug delivery solutions with a strong focus on leveraging innovation to provide patient-focused solutions, Aptar allocate 5% of annual revenue to research and development.
Identity